Cancer Treatment Reviews
Volume 35, Issue 8 , Pages 692-706 , December 2009

Clinical pharmacokinetics of tyrosine kinase inhibitors

  • Nielka P. van Erp

      Affiliations

    • Departments of Clinical Pharmacy and Toxicology, University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Room L0-042, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Tel.: +31 71 5262755.
    • ,
  • Hans Gelderblom

      Affiliations

    • Departments of Clinical Oncology, University Medical Center, Leiden, The Netherlands
    • ,
  • Henk-Jan Guchelaar

      Affiliations

    • Departments of Clinical Pharmacy and Toxicology, University Medical Center, Leiden, The Netherlands

Received 23 March 2009 ,Revised 3 August 2009 ,Accepted 6 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(09)00116-9

doi: 10.1016/j.ctrv.2009.08.004

Cancer Treatment Reviews
Volume 35, Issue 8 , Pages 692-706 , December 2009

Article Tools

* Image Usage & Resolution